Action | Baseline period | Study visits | Telephone visits |
---|---|---|---|
Informed consent | X | Â | Â |
Checking inclusion and exclusion criteria | X | Â | Â |
Demographics | X | Â | Â |
Medical history (with focus on liver disease) | X | Â | Â |
NOD2 genetic testing | X | Â | Â |
Concomitant diseases | X | X | X |
Concomitant medications | X | X | X |
MELD and Child-Pugh-scores | X | X | Â |
Clinical assessment and vital signs | X | X | Â |
12-lead ECG | X | X | Â |
Blood tests (safety parameters) | X | X | Â |
Recording of adverse events | Â | X | X |
Distribution and return of study medication | Â | X | Â |
Collection of ascites samples (clinically indicated puncture) | X | X | Â |
Collection of stool samples | Â | X | Â |